Product: ERBITUX CETUXIMAB Injection, 200 mg/100 mL (2 mg/mL), 100 mL per single-use vial, Rx only, Manufactured by:  ImClone LLC, a wholly-owned subsidiary of Eli Lilly and Company, Branchburg, NJ 08876 USA.  NDC: 66733-958-23
Reason for recall: Labeling: Missing label; potential for missing primary container label on the vial.
Recall initiated: 20181108
Status: Terminated
Classification: Class III
Recall type: Voluntary: Firm initiated